Live Breaking News & Updates on Less Likely|Page 7

Stay updated with breaking news from Less likely. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Melt Pharmaceuticals' MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study

Melt Pharmaceuticals' MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Larry Dillaha , John Berdahl , Deb Holliday , Catalent Inc , Harrow Health Inc , Drug Administration , Pharmaceuticals Inc , Holliday Communications Inc , Procedural Sedation Compared , All Comparator Treatment Arms , Including Midazolam , Less Likely , Require Rescue Sedation Compared , Require Rescue Sedation Pre Operatively Compared , Midazolam Treatment , Ramsay Sedation Scale , Melt Pharmaceuticals , North America , Harrow Health ,